177 related articles for article (PubMed ID: 25030863)
21. Clinical significance of microRNA-34a in esophageal squamous cell carcinoma.
Lin X; Xu XY; Chen QS; Huang C
Genet Mol Res; 2015 Dec; 14(4):17684-91. PubMed ID: 26782413
[TBL] [Abstract][Full Text] [Related]
22. Upregulated miR-483-5p expression as a prognostic biomarker for esophageal squamous cell carcinoma.
Xue L; Nan J; Dong L; Zhang C; Li H; Na R; He H; Wang Y
Cancer Biomark; 2017; 19(2):193-197. PubMed ID: 28211800
[TBL] [Abstract][Full Text] [Related]
23. The global expression profiling in esophageal squamous cell carcinoma.
Dai F; Mei L; Meng S; Ma Z; Guo W; Zhou J; Zhang J
Genomics; 2017 Jul; 109(3-4):241-250. PubMed ID: 28442363
[TBL] [Abstract][Full Text] [Related]
24. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
[TBL] [Abstract][Full Text] [Related]
25. MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway.
Ishibashi O; Akagi I; Ogawa Y; Inui T
Biochem Biophys Res Commun; 2018 Jun; 501(2):507-513. PubMed ID: 29738771
[TBL] [Abstract][Full Text] [Related]
26. Altered miRNA expression is associated with differentiation, invasion, and metastasis of esophageal squamous cell carcinoma (ESCC) in patients from Huaian, China.
Fu HL; Wu DP; Wang XF; Wang JG; Jiao F; Song LL; Xie H; Wen XY; Shan HS; Du YX; Zhao YP
Cell Biochem Biophys; 2013 Nov; 67(2):657-68. PubMed ID: 23516093
[TBL] [Abstract][Full Text] [Related]
27. Identification of prognostic miRNA biomarkers for esophageal cancer based on The Cancer Genome Atlas and Gene Expression Omnibus.
Xue J; Jia E; Ren N; Xin H
Medicine (Baltimore); 2021 Feb; 100(7):e24832. PubMed ID: 33607850
[TBL] [Abstract][Full Text] [Related]
28. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
Kimura S; Naganuma S; Susuki D; Hirono Y; Yamaguchi A; Fujieda S; Sano K; Itoh H
Oncol Rep; 2010 Jun; 23(6):1625-33. PubMed ID: 20428818
[TBL] [Abstract][Full Text] [Related]
29. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway.
Mei LL; Qiu YT; Huang MB; Wang WJ; Bai J; Shi ZZ
Cancer Biomark; 2017 Dec; 20(4):527-537. PubMed ID: 28800315
[TBL] [Abstract][Full Text] [Related]
30. Complex Epigenetic Regulation of Chemotherapy Resistance and Biohlogy in Esophageal Squamous Cell Carcinoma via MicroRNAs.
Lindner K; Eichelmann AK; Matuszcak C; Hussey DJ; Haier J; Hummel R
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29414899
[TBL] [Abstract][Full Text] [Related]
31. Plasma miR-185 is decreased in patients with esophageal squamous cell carcinoma and might suppress tumor migration and invasion by targeting RAGE.
Jing R; Chen W; Wang H; Ju S; Cong H; Sun B; Jin Q; Chu S; Xu L; Cui M
Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G719-29. PubMed ID: 26316588
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of miR-138 predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Zheng S; Zhang X; Wang X; Li J
Cancer Biomark; 2017 Jul; 20(1):49-54. PubMed ID: 28759955
[TBL] [Abstract][Full Text] [Related]
33. MiR-630 inhibits invasion and metastasis in esophageal squamous cell carcinoma.
Jin L; Yi J; Gao Y; Han S; He Z; Chen L; Song H
Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):810-9. PubMed ID: 27563011
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
[TBL] [Abstract][Full Text] [Related]
35. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA signatures in chemotherapy resistant esophageal cancer cell lines.
Hummel R; Sie C; Watson DI; Wang T; Ansar A; Michael MZ; Van der Hoek M; Haier J; Hussey DJ
World J Gastroenterol; 2014 Oct; 20(40):14904-12. PubMed ID: 25356050
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis.
Li M; He XY; Zhang ZM; Li S; Ren LH; Cao RS; Feng YD; Ji YL; Zhao Y; Shi RH
World J Gastroenterol; 2015 Mar; 21(11):3245-55. PubMed ID: 25805931
[TBL] [Abstract][Full Text] [Related]
38. Plasma miRNA-506 as a Prognostic Biomarker for Esophageal Squamous Cell Carcinoma.
Li SP; Su HX; Zhao D; Guan QL
Med Sci Monit; 2016 Jun; 22():2195-201. PubMed ID: 27345473
[TBL] [Abstract][Full Text] [Related]
39. MiR-139-5p regulates VEGFR and downstream signaling pathways to inhibit the development of esophageal cancer.
Jiao W; Zhang J; Wei Y; Feng J; Ma M; Zhao H; Wang L; Jiao W
Dig Liver Dis; 2019 Jan; 51(1):149-156. PubMed ID: 30245290
[TBL] [Abstract][Full Text] [Related]
40. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
